FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease | Landmark decision heralds a new type of medicine that can tackle genetic conditions that are hard to treat
The key thing about this kind of therapy is that it’s not a drug you keep on taking - it’s a one-time thing which permanently cures the disease.
![](https://kbin.life/media/cache/resolve/entry_thumb/26/1d/261dae7a74aee47bd9fdfa6d899a3dc5c69cd633bcafa1d6d4d81f2dad8c9f3a.jpg)